Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 25;13(9):e0203860.
doi: 10.1371/journal.pone.0203860. eCollection 2018.

Non-parametric estimation of survival in age-dependent genetic disease and application to the transthyretin-related hereditary amyloidosis

Affiliations

Non-parametric estimation of survival in age-dependent genetic disease and application to the transthyretin-related hereditary amyloidosis

Flora Alarcon et al. PLoS One. .

Abstract

In genetic diseases with variable age of onset, survival function estimation for the mutation carriers as well as estimation of the modifying factors effects are essential to provide individual risk assessment, both for mutation carriers management and prevention strategies. In practice, this survival function is classically estimated from pedigrees data where most genotypes are unobserved. In this article, we present a unifying Expectation-Maximization (EM) framework combining probabilistic computations in Bayesian networks with standard statistical survival procedures in order to provide mutation carrier survival estimates. The proposed approach allows to obtain previously published parametric estimates (e.g. Weibull survival) as particular cases as well as more general Kaplan-Meier non-parametric estimates, which is the main contribution. Note that covariates can also be taken into account using a proportional hazard model. The whole methodology is both validated on simulated data and applied to family samples with transthyretin-related hereditary amyloidosis (a rare autosomal dominant disease with highly variable age of onset), showing very promising results.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no competing interests exist.

Figures

Fig 1
Fig 1. Simulated dataset.
Reference and estimation of the survival function S(t) for carriers with 95% point-wise confidence intervals (dashed lines). A total of n = 3,285 (1,641 males and 1,644 females) individuals including 441 affected and 319 genotyped. Left: simulation and estimation without gender effect. Right: simulation and estimation with a proportional protective effect for females (gender = 2).
Fig 2
Fig 2. Survival estimates.
Top-Left: French dataset with a gender PH effect (RH 1.7, Cox’s p-value 0.030); Top-Right: Portugese dataset with a gender PH effect (RH 1.57, Cox’s p-value 0.033); Bottom-Left: Swedish dataset with a non-significant gender PH effect (Cox’s p-value 0.42). Bottom-Right: Swedish dataset without any gender PH effect. 95% point-wise confidence intervals are given by the colored regions.

Similar articles

Cited by

References

    1. Le Bihan C, Moutou C, Brugieres L, Feunteun J, Bonaïti-Pellié C. ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data. Genet Epidemiol. 1995;12(1):13–25. 10.1002/gepi.1370120103 - DOI - PubMed
    1. Plante-Bordeneuve V, Carayol J, Ferreira A, Adams D, Clerget-Darpoux F, Misrahi M, et al. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families. J Med Genet. 2003;40(11):e120 10.1136/jmg.40.11.e120 - DOI - PMC - PubMed
    1. Carayol J, Bonaïti-Pellié C. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset. Genetic Epidemiology. 2004;27(2):109–117. 10.1002/gepi.20007 - DOI - PubMed
    1. Easton D, Bishop D, Ford D, Crockford G. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. American journal of human genetics. 1993;52(4):678 - PMC - PubMed
    1. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, et al. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. American journal of human genetics. 1997;60(5):1021 - PMC - PubMed

Supplementary concepts